Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Godman, Brian ORCID: 0000-0001-6539-6972, Bucsics, Anna, Bonanno, Patricia Vella, Oortwijn, Wija, Rothe, Celia C, Ferrario, Alessandra, Bosselli, Simone, Hill, Andrew, Martin, Antony P ORCID: 0000-0003-4383-6038, Simoens, Steven
et al (show 42 more authors) (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. FRONTIERS IN PUBLIC HEALTH, 6 (DEC). 328-.


Malmström, Rickard E, Godman, Brian B ORCID: 0000-0001-6539-6972, Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Ferrario, Alessandra
et al (show 37 more authors) (2013) Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs. Frontiers in Pharmacology, 4 (39).


Godman, Brian, McCabe, Holly, Leong, Trudy D, Mueller, Debjani, Martin, Antony P ORCID: 0000-0003-4383-6038, Hoxha, Iris, Mwita, Julius C, Rwegerera, Godfrey Mutashambara, Massele, Amos, Costa, Juliana de Oliveira
et al (show 45 more authors) (2020) Fixed dose drug combinations - are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 20 (1). pp. 1-26.


Ferrario, Alessandra, Araja, Diana, Bochenek, Tomasz, Catic, Tarik, Danko, David, Dimitrova, Maria, Furst, Jurij, Greiciute-Kuprijanov, Ieva, Hoxha, Iris, Jakupi, Arianit
et al (show 14 more authors) (2017) The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. PHARMACOECONOMICS, 35 (12). pp. 1271-1285.


Godman, Brian ORCID: 0000-0001-6539-6972, Finlayson, Alexander E, Cheema, Parneet K, Zebedin-Brandl, Eva, Gutiérrez-Ibarluzea, Inaki ORCID: 0000-0002-4080-7963, Jones, Jan, Malmström, Rickard E, Asola, Elina, Baumgärtel, Christoph, Bennie, Marion
et al (show 35 more authors) (2013) Personalizing health care: feasibility and future implications. BMC medicine, 11 (1). 179-.


Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Selke Krulichová, Iva, Zampirolli Dias, Carolina, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Timoney, Angela, Gustafsson, Lars
et al (show 40 more authors) (2021) Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. Expert review of pharmacoeconomics & outcomes research, 21 (4). pp. 527-540.


Godman, Brian ORCID: 0000-0001-6539-6972, Hill, Andrew, Simoens, Professor Steven, Kurdi, Amanj, Gulbinovic, Jolanta, Martin, Antony P ORCID: 0000-0003-4383-6038, Timoney, Angela, Gotham, Dzintars, Wale, Janet, Bochenek, Tomasz
et al (show 38 more authors) (2019) Pricing of oral generic cancer medicines in 25 European countries; findings and implications. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 8 (2). pp. 49-70.


Bonanno, Patricia Vella, Bucsics, Anna, Simoens, Steven, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Gulbinovic, Jolanta, Rothe, Celia, Timoney, Angela, Ferrario, Alessandra, Gad, Mohamed
et al (show 26 more authors) (2019) Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 19 (3). pp. 251-261.

This list was generated on Sat Mar 2 07:42:04 2024 GMT.